Los Angeles, CA -- (SBWIRE) -- 01/08/2019 -- This report studies the global Immuno-oncology Drugs market status and forecast, categorizes the global Immuno-oncology Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Immuno-oncology Drugs market is valued at 49200 million US$ in 2017 and will reach 142200 million US$ by the end of 2025, growing at a CAGR of 14.2% during 2018-2025.

Request Sample Report Copy@ https://www.qyresearch.com/sample-form/form/547629/global-immuno-oncology-drugs-market

The major manufacturers covered in this report

Amgen, Inc

AstraZeneca, Plc

Bristol-Myers Squibb

Celgene Corporation

Eli Lilly and Company

Merck & Co.

Hoffmann-La Roche AG

Johnson & Johnson

Novartis International AG

AbbVie, Inc.

Pfizer Inc.

Sanofi S.A.

EMD Serono, Inc.

Gilead Sciences Inc.

Prometheus Therapeutics & Diagnostics

Aduro BioTech

Galena Biopharma

Bavarian Nordic

Celldex Therapeutics

ImmunoCellular Therapeutics

Incyte

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America

Europe

China

Japan

Southeast Asia

India

Get Amazing Discount on Market Research Report@ https://www.qyresearch.com/request-discount/form/547629/global-immuno-oncology-drugs-market
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.